AMGEN INC (AMGN)
About AMGEN INC
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $36.8B
- Net income
- $7.7B
- Total assets
- $90.6B
- Market cap
- $203.0B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $203.0B
- Dividend yield
- 2.25%
- Shares outstanding
- 453.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 17, 1983
Amgen Inc (AMGN) Stock Price
- Profitable — net income of $7.7B in FY2025.
- Trading near its 52-week high.
- Pays a dividend yielding about 2.25% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review AMGEN INC.
Write a review
News about AMGEN INC
News & sentiment via Polygon.io
Amgen Inc: frequently asked questions
Is Amgen Inc an American company?
Yes — Amgen Inc is an American company. Amgen Inc is incorporated in Delaware, United States and headquartered in Thousand Oaks, California. Its legal-entity record reports no foreign parent — the company is independently American-owned.
Where is Amgen Inc incorporated?
Amgen Inc is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.
Who owns Amgen Inc?
Amgen Inc reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.
Is Amgen Inc traded on a US stock exchange?
Yes — Amgen Inc trades under the ticker AMGN on the NASDAQ.
Where is Amgen Inc headquartered?
Amgen Inc is headquartered in Thousand Oaks, California, United States.
Is Amgen Inc publicly traded?
Yes — Amgen Inc is a publicly traded company. Its stock trades under the ticker symbol AMGN on the NASDAQ.
What does Amgen Inc do?
Amgen Inc is an American Pharmaceuticals company in the Health & Beauty sector.
When was Amgen Inc founded?
Amgen Inc was founded in 1980.
